These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30783329)

  • 1. A case of capecitabine-induced dermatomyositis.
    Saraswat N; Verma R; Neema S; Kumar S
    Indian J Pharmacol; 2018; 50(6):350-353. PubMed ID: 30783329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatomyositis associated with capecitabine in the setting of malignancy.
    Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY
    J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983
    [No Abstract]   [Full Text] [Related]  

  • 3. Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer.
    Cobos GA; Nelson CA; Alsarheed A; LaChance A; Laga AC; LeBoeuf N; Vleugels RA
    JAMA Dermatol; 2020 Jan; 156(1):103-104. PubMed ID: 31693064
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.
    Lou Y; Wang Q; Zheng J; Hu H; Liu L; Hong D; Zeng S
    Chem Res Toxicol; 2016 Oct; 29(10):1591-1601. PubMed ID: 27631426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral Capecitabine-related Hand-foot Syndrome.
    Matsuda S; Koketsu H; Hayakawa M; Nagata N
    Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
    [No Abstract]   [Full Text] [Related]  

  • 7. Capecitabine-induced lichenoid drug eruption: a case report.
    Gehlhausen JR; Strausburg MB; Aouthmany M; Katona TM; Turner MJ
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
    Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature.
    Zurayk M; Keung YK; Yu D; Hu EH
    J Oncol Pharm Pract; 2019 Jan; 25(1):234-238. PubMed ID: 28950804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
    Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
    Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine for treating head and neck cancer.
    Iqbal H; Pan Q
    Expert Opin Investig Drugs; 2016 Jul; 25(7):851-9. PubMed ID: 27144283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impressive Response to Capecitabine in a Patient with Obstructive Jaundice due to Metastatic Triple-Negative Breast Cancer.
    Sattwika PD; Oktariani S; Leo B; Sagiran ; Iqbal M; Choridah L; Bayupurnama P; Kurnianda J; Hutajulu SH
    Oncol Res Treat; 2019; 42(11):607-611. PubMed ID: 31557756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of two cases of acute cardiac adverse events in patients with colorectal carcinoma receiving oral capecitabine.
    Lampropoulos S; Roditis P; Koulouris E; Zafiris A; Tzimou M; Kyratlidis K; Pavlidis K; Godwin SA; Kosmas C
    Anticancer Drugs; 2017 Aug; 28(7):801-807. PubMed ID: 28489615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in asian cancer patients in clinical practice.
    Phua VC; Wong WQ; Tan PL; Bustam AZ; Saad M; Alip A; Wan Ishak WZ
    Asian Pac J Cancer Prev; 2015; 16(4):1449-53. PubMed ID: 25743814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
    Suto T; Ishiguro M; Hamada C; Kunieda K; Masuko H; Kondo K; Ishida H; Nishimura G; Sasaki K; Morita T; Hazama S; Maeda K; Mishima H; Ike H; Sadahiro S; Sugihara K; Okajima M; Saji S; Sakamoto J; Tomita N
    Int J Clin Oncol; 2017 Jun; 22(3):494-504. PubMed ID: 28078540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation recall myelitis following capecitabine: First case report.
    Guerreiro C; Albuquerque L; Reimão S
    Clin Neurol Neurosurg; 2020 Sep; 196():105978. PubMed ID: 32540712
    [No Abstract]   [Full Text] [Related]  

  • 17. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome?
    Do JE; Kim YC
    Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A life-threatening drug-drug interaction between capecitabine and brivudine in a patient with metastatic breast cancer.
    Tsifi A; Papaxoinis G; Diamantopoulos P; Mantzourani M; Antoniadou V; Halioti A; Gogas H
    J Chemother; 2019; 31(7-8):424-427. PubMed ID: 31516092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic dermatomyositis triggered and exacerbated by oral 5-fluorouracil administration.
    Kawachi Y; Koike Y; Kano T; Furuta J; Fujisawa Y; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
    Eur J Dermatol; 2008; 18(2):195-6. PubMed ID: 18424388
    [No Abstract]   [Full Text] [Related]  

  • 20. Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review.
    Saneeymehri SS; Markey KR; Mahipal A
    J Oncol Pharm Pract; 2016 Jun; 22(3):552-5. PubMed ID: 25852107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.